Symbiotec Pharmalab IPO GMP In Focus As Issue Opens For Subscription

As reported by NDTV Profit - Latest

Symbiotec Pharmalab IPO opened on Aug. 24 with a Rs 1,757 crore issue. GMP signals a 40% listing gain at the upper price band.

▸ MARKET SAMACHAR VIEW

NEUTRAL

Read full article on NDTV Profit - Latest ↗

Market Samachar is a news aggregator. This article was originally published by NDTV Profit - Latest. Tap the button above to read the full story on their site.

COMPANIES IPO fund diversion: Sebi bars Varanium Cloud, promoter for 7 years from markets Stocks-Markets-Economic Times
COMPANIES HEG demerger to take effect on September 1; record date fixed for September 7 Stocks-Markets-Economic Times
INDIAN US stocks today: US stocks open higher as tech stocks rebound before Nvidia results, data Markets-Economic Times
INDIAN Euro zone yields dip from multi-year highs as oil falls on Iran sanctions Markets-Economic Times
INDIAN Sterling hovers near six-month high underpinned by BoE rate hike expectations Markets-Economic Times
INDIAN UK gilt yields fall to lowest since mid-August as oil price slides Markets-Economic Times
INDIAN RBI net absorbed $561 million in June as inflows picked up Markets-Economic Times
INDIAN Fortune expands its mustard oil portfolio with launch of Yellow Mustard Oil Share Market Today

Symbiotec Pharmalab IPO GMP In Focus As Issue Opens For Subscription

More from Market Samachar